RESECTABLE NSCLC

Clinical trials for RESECTABLE NSCLC explained in plain language.

Never miss a new study

Get alerted when new RESECTABLE NSCLC trials appear

Sign up with your email to follow new studies for RESECTABLE NSCLC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New combo treatment aims to shrink lung tumors before surgery

Disease control Recruiting now

This study is testing whether combining an immunotherapy drug (tislelizumab) with targeted radiation before surgery can help shrink or eliminate tumors in people with operable non-small cell lung cancer. The goal is to see if this pre-surgery treatment makes the cancer easier to …

Matched conditions: RESECTABLE NSCLC

Phase: PHASE2 • Sponsor: Northern Jiangsu People's Hospital • Aim: Disease control

Last updated Apr 02, 2026 03:56 UTC

RESECTABLE NSCLC

Get alerted when new RESECTABLE NSCLC trials appear

New combo treatment aims to shrink lung tumors before surgery